XML 21 R11.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Fair Value Measurements | 3 Months Ended
--- | ---
Mar. 31, 2018
Fair Value Disclosures [Abstract] |
FAIR VALUE MEASUREMENTS | FAIR VALUE MEASUREMENTS At March 31, 2018 and December 31, 2017, the Company had derivative assets totaling $2.3 million and $1.9 million, respectively, and derivative liabilities totaling $2.8 million and $2.4 million, respectively. The fair values of the interest rate swap agreement and foreign currency forward contracts that economically hedge short-term intercompany balances are estimated based upon inputs from current valuation information obtained from dealer quotes and priced with observable market assumptions and appropriate valuation adjustments for credit risk. The Company has evaluated the valuation methodologies used to develop the fair values by dealers in order to determine whether such valuations are representative of an exit price in the Company’s principal market. In addition, the Company uses an internally developed model to perform testing on the valuations received from brokers. The Company has also considered both its own credit risk and counterparty credit risk in determining fair value and determined these adjustments were insignificant at March 31, 2018 and December 31, 2017. At March 31, 2018 and December 31, 2017, the Company had $10.4 million and $5.6 million of cash equivalents, respectively, the fair value of which is determined through quoted and corroborated prices in active markets. The fair value of cash equivalents approximates cost. The fair value of the Company's fixed interest rate debt was estimated using Level 2 inputs, primarily discounted cash flow models, based on estimated current rates offered for similar debt under current market conditions for the Company. The carrying value of the Company's debt exceeds the fair value by approximately $0.4 million as of March 31, 2018. The fair value of the contingent consideration obligation of $30.9 million relating to the Biotix acquisition as of March 31, 2018 is based on the Company's forecast of future results. The fair value measurements are based on significant inputs not observable in the market and thus represent a Level 3 measurement. Under U.S. GAAP, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement consists of observable and unobservable inputs that reflect the assumptions that a market participant would use in pricing an asset or liability. A fair value hierarchy has been established that categorizes these inputs into three levels:
Level 1: | Quoted prices in active markets for identical assets and liabilities
Level 2: | Observable inputs other than quoted prices in active markets for identical assets and liabilities
Level 3: | Unobservable inputs
The following table presents for each of these hierarchy levels, the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2018 and December 31, 2017:
| March 31, 2018 |  | December 31, 2017
| Total |  | Level 1 |  | Level 2 |  | Level 3 |  | Total |  | Level 1 |  | Level 2 |  | Level 3
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents | $ | 10,364 |  |  | $ | — |  |  | $ | 10,364 |  |  | $ | — |  |  | $ | 5,616 |  |  | $ | — |  |  | $ | 5,616 |  |  | $ | — |
Interest rate swap agreements | 976 |  |  | — |  |  | 976 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Foreign currency forward contracts not designated as hedging instruments | 1,371 |  |  | — |  |  | 1,371 |  |  | — |  |  | 1,912 |  |  | — |  |  | 1,912 |  |  | — |
Total | $ | 12,711 |  |  | $ | — |  |  | $ | 12,711 |  |  | $ | — |  |  | $ | 7,528 |  |  | $ | — |  |  | $ | 7,528 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate swap agreements | $ | 126 |  |  | $ | — |  |  | $ | 126 |  |  | $ | — |  |  | $ | 1,292 |  |  | $ | — |  |  | $ | 1,292 |  |  | $ | — |
Cross currency swap agreement | 2,043 |  |  | — |  |  | 2,043 |  |  | — |  |  | 106 |  |  | — |  |  | 106 |  |  | — |
Foreign currency forward contracts not designated as hedging instruments | 659 |  |  | — |  |  | 659 |  |  | — |  |  | 986 |  |  | — |  |  | 986 |  |  | — |
Total | $ | 2,828 |  |  | $ | — |  |  | $ | 2,828 |  |  | $ | — |  |  | $ | 2,384 |  |  | $ | — |  |  | $ | 2,384 |  |  | $ | — |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -URI http://asc.fasb.org/topic&trid=2155941 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration